ID   GC3/M TK-
AC   CVCL_1B33
SY   GC3/MTK-
DR   ChEMBL-Cells; CHEMBL3307886
DR   ChEMBL-Targets; CHEMBL614157
DR   PubChem_Cell_line; CVCL_1B33
DR   Wikidata; Q54835489
RX   PubMed=3829001;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1B32 ! GC3/M
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 9
//
RX   PubMed=3829001;
RA   Houghton P.J., Houghton J.A., Germain G., Torrance P.M.;
RT   "Development and characterization of a human colon adenocarcinoma
RT   xenograft deficient in thymidine salvage.";
RL   Cancer Res. 47:2117-2122(1987).
//